FindTrial
Sign In

comparision between Tramadol and Ketamine in prevention of shivering in TURP

To compare the efficacy of intravenous Tramadol and Ketamine for prevention of shivering in patients undergoing transurethral resection of prostate under spinal anaesthesia - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090863
Enrollment
90
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: tramadol: Tramadol (0.5mg/kg) in 10ml normal saline IV infusion over 5 minutes Intervention2: ketamine: Ketamine (0.25mg/kg) in 10ml normal saline IV infusion over 5 minutes Control Int

Sponsors

PGIMS ROHTAK Pt BD Sharma University Of Health Scienca
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to the American Society of Anaesthesiologists- Physical Status I and II and aged between 40 and 75years undergoing elective TURP under spinal anaesthesia

Exclusion criteria

Exclusion criteria: patients refusing to give consent, hypersensitivity to study drugs, who develop shivering before administeration to study drugs, patients on vasodilators/ vasocontrictors

Design outcomes

Primary

MeasureTime frame
Both Tramadol and Ketamine have been succesfully used for their prophylactic role in shivering after neuraxial anaesthesiaTimepoint: we will assess the shivering if any, every 5 minutes intraoperatively and every 10 minutes post operatively for 1 hour—

Secondary

MeasureTime frame
To evaluate adverse effects associated with use of study drugs , if any like nausea/vomiting, sedation, hypotension also bradycardiaTimepoint: Adverse effects will be assessed intra operatively as well as 1 hour after the surgery—

Countries

India

Contacts

Public ContactDr Anju Rani

Pt, BD Sharma PGIMS Rohtak

anjudahiya88@gmail.com9540526120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026